DexCom, Inc. (DC4.DE)
| Previous Close | 74.19 |
| Open | 74.23 |
| Bid | 73.62 x N/A |
| Ask | 73.76 x N/A |
| Day's Range | 73.57 - 74.23 |
| 52 Week Range | 58.01 - 131.78 |
| Volume | |
| Avg. Volume | 349 |
| Market Cap | 29.003B |
| Beta (5Y Monthly) | 1.17 |
| PE Ratio (TTM) | 46.94 |
| EPS (TTM) | 1.58 |
| Earnings Date | Feb 06, 2025 - Feb 10, 2025 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Insider MonkeyWhy Is DexCom, Inc. (DXCM) Among the Worst Performing Healthcare Stocks in 2024?
We recently compiled a list of the 10 Worst Performing Healthcare Stocks in 2024. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against the other healthcare stocks. The Evolving Landscape of Global Healthcare Spending and Innovation The healthcare industry remains a vital and resilient sector which is driven […]
ZacksWhy DexCom (DXCM) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- Insider Monkey
DexCom, Inc. (DXCM): Innovation and Growth Catalysts Amid Strong Long-Term Outlook for Diabetes Care
We recently compiled a list of the Wells Fargo’s Best Growth Stocks: 28 Stocks With The Highest Consensus EPS Growth Estimates. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against Well Fargo’s other growth stocks. With the interest rate cycle kicking off in the US, stocks that are […]
